United Therapeutics (UTHR) Short-Term Debt repayments (2019 - 2025)
Historic Short-Term Debt repayments for United Therapeutics (UTHR) over the last 7 years, with Q2 2025 value amounting to $400.0 million.
- United Therapeutics' Short-Term Debt repayments rose 30000.0% to $400.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $600.0 million, marking a year-over-year increase of 5000.0%. This contributed to the annual value of $400.0 million for FY2024, which is 30000.0% up from last year.
- Latest data reveals that United Therapeutics reported Short-Term Debt repayments of $400.0 million as of Q2 2025, which was up 30000.0% from $100.0 million recorded in Q1 2025.
- United Therapeutics' 5-year Short-Term Debt repayments high stood at $800.0 million for Q1 2022, and its period low was $100.0 million during Q4 2023.
- Moreover, its 4-year median value for Short-Term Debt repayments was $100.0 million (2023), whereas its average is $225.0 million.
- In the last 5 years, United Therapeutics' Short-Term Debt repayments changed by 0.0% in 2024 and then soared by 30000.0% in 2025.
- United Therapeutics' Short-Term Debt repayments (Quarter) stood at $800.0 million in 2022, then crashed by 87.5% to $100.0 million in 2023, then changed by 0.0% to $100.0 million in 2024, then skyrocketed by 300.0% to $400.0 million in 2025.
- Its Short-Term Debt repayments was $400.0 million in Q2 2025, compared to $100.0 million in Q1 2025 and $100.0 million in Q4 2024.